XYNOMIC PHARMACEUTICALS
Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies.Xynomic Pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in China, US and rest of the world. Xynomic Pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner.
XYNOMIC PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2016-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.xynomicpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Microsoft Azure DNS
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Ascentage Pharma
Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Cyclerion Therapeutics
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company.
Eledon Pharmaceuticals
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company
Xenon Pharmaceuticals
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
Current Employees Featured
Founder
Investors List
Prosperico Ventures
Prosperico Ventures investment in Series B - Xynomic Pharmaceuticals
Northern Light Venture Capital
Northern Light Venture Capital investment in Series B - Xynomic Pharmaceuticals
Hakim Unique Internet
Hakim Unique Internet investment in Series B - Xynomic Pharmaceuticals
Zhongshan Bison Healthcare Investment
Zhongshan Bison Healthcare Investment investment in Series B - Xynomic Pharmaceuticals
Official Site Inspections
http://www.xynomicpharma.com Semrush global rank: 4.79 M Semrush visits lastest month: 1.91 K
- Host name: 213.233.12.198.host.secureserver.net
- IP address: 198.12.233.213
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Xynomic Pharmaceuticals"
徐诺药业 – Xynomic Pharmaceuticals Holdings, Inc.
Latest News. Y. Mark Xu talks with CGTN (China Global TV Network) 10/26/2018 Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy Treating Follicular Lymphoma 09/26/2019; …See details»
Xynomic Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The …See details»
Xynomic Pharmaceuticals Company Profile | Management and
[email protected]: 6: last: [email protected]: Your Questions, Our Answers Get Free Access to Xynomic Pharmaceuticals Contacts Info. What is Xynomic …See details»
Xynomic Pharmaceuticals - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Xynomic Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Overview, News & Similar companies - ZoomInfo.com
Jun 17, 2021 Who is Xynomic Pharmaceuticals. Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage oncology-focused biopharmaceutical company. Its current pipeline mainly …See details»
Xynomic Pharmaceuticals - Craft
Jun 22, 2021 Xynomic Pharmaceuticals is a clinical-stage oncology therapeutics biopharmaceutical company. It focuses on in-licensing, developing, and commercializing …See details»
Xynomic Pharmaceuticals Inc - Company Profile and News
Company profile page for Xynomic Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
English – 徐诺药业 - Xynomic Pharma
Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy Treating Follicular Lymphoma 09/26/2019 news admin. September 23, 2019 06:00 …See details»
Xynomic Pharma - In-licensing, developing and ... - LinkedIn
In-licensing, developing and commercializing oncology drug candidates at Xynomic Pharma · Xynomic Pharmaceuticals, Inc. is a US incorporated biopharmaceutical company founded by …See details»
Xynomic Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Xynomic Pharmaceuticals, Inc. of Dover, DE. Get the latest business insights from Dun & Bradstreet.See details»
Xynomic Pharma - 2025 Company Profile - Tracxn
Apr 27, 2025 Xynomic Pharma - Targeted small molecule therapeutics for cancer. Public Company. Raised funding over 1 round from 6 investors. Xynomic Pharma has 3571 competitors.See details»
Home – 徐诺药业 - Xynomic Pharma
Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy Treating Follicular Lymphoma 09/26/2019. September 23, 2019 06:00 ET | Source: …See details»
Bison Capital Acquisition Corp. and Xynomic ... - Xynomic Pharma
Latest News. Y. Mark Xu talks with CGTN (China Global TV Network) 10/26/2018 Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy …See details»
Management – 徐诺药业 - Xynomic Pharma
Latest News. Y. Mark Xu talks with CGTN (China Global TV Network) 10/26/2018 Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy …See details»
徐诺药业 – Xynomic Pharmaceuticals Holdings, Inc.
徐诺药业(南京)有限公司是一家以患者需求为导向专注开发抗肿瘤药物的全球性生物制药公司，在自主研发和License in（授权引进）双引擎驱动下，旨在为全球患者提供更有效的治疗方案。 …See details»
Xynomic Pharmaceuticals, Inc. (Xynomic Pharmaceuticals, Inc.) - 药 …
了解Xynomic Pharmaceuticals, Inc. (Xynomic Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的13项临床试验, 34篇新闻和1篇文献，疾病领域:肿瘤，内分泌与代谢疾 …See details»
Xynomic Pharmaceuticals - VentureRadar
Website: http://xynomicpharma.com/ Develops oncology-focused biopharmaceuticals with a pipeline consisting of three drug candidates, targeting renal cell carcinoma ...See details»
Xynomic Closed a Short Form Merger for "Going Private" …
Jun 17, 2021 --Xynomic Pharmaceuticals Holdings, Inc., a clinical stage US-China oncology drug development company, announced that it closed a short form merger with and into Xu …See details»
Xynomic Pharma Achieves Important Regulatory Milestones in …
Mar 16, 2019 RALEIGH, N.C. and SHANGHAI, March 16, 2019 /PRNewswire/ -- Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital …See details»
Xynomic Pharma Acquires Global Exclusive Rights to Phase 2 …
Dec 20, 2018, 10:52 ET. DOVER, Del. and SHANGHAI, Dec. 20, 2018 /PRNewswire/ — Xynomic Pharmaceuticals, Inc. (“Xynomic”), a clinical stage US-China oncology drug development …See details»